AR015537A1 - Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina. - Google Patents
Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina.Info
- Publication number
- AR015537A1 AR015537A1 ARP990100980A ARP990100980A AR015537A1 AR 015537 A1 AR015537 A1 AR 015537A1 AR P990100980 A ARP990100980 A AR P990100980A AR P990100980 A ARP990100980 A AR P990100980A AR 015537 A1 AR015537 A1 AR 015537A1
- Authority
- AR
- Argentina
- Prior art keywords
- brinzolamide
- manufacture
- treat
- medicinal product
- retina edema
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El uso de brinzolamida para la fabricacion de un medicamento para tratar o prevenir el edema de retina que comprende una cantidad farmacéuticamenteefectiva de brinzolamida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/036,960 US5948801A (en) | 1998-03-09 | 1998-03-09 | Treatment of retinal edema with brinzolamide |
Publications (1)
Publication Number | Publication Date |
---|---|
AR015537A1 true AR015537A1 (es) | 2001-05-02 |
Family
ID=21891660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990100980A AR015537A1 (es) | 1998-03-09 | 1999-03-08 | Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina. |
Country Status (5)
Country | Link |
---|---|
US (1) | US5948801A (es) |
AR (1) | AR015537A1 (es) |
AU (1) | AU2573099A (es) |
WO (1) | WO1999045929A1 (es) |
ZA (1) | ZA991224B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004073708A1 (en) * | 1998-12-17 | 2004-09-02 | Dean Thomas R | Brinzolamide and brimonidine for treating ocular conditions |
EP1938799B1 (en) * | 2000-03-10 | 2013-05-08 | Insite Vision Incorporated | Compositions for treating and preventing posterior segment ophthalmic disorders and use thereof |
US7141607B1 (en) | 2000-03-10 | 2006-11-28 | Insite Vision Incorporated | Methods and compositions for treating and inhibiting retinal neovascularization |
DE60110087T2 (de) * | 2000-08-11 | 2005-09-29 | Einar Stefansson | Verwendung von Carboanhydrase-Inhibitoren zur Prävention von diabetischer Retinopathie bei Diabetikern |
US20110021974A1 (en) * | 2010-10-05 | 2011-01-27 | Shantha Totada R | Retinitis pigmentosa treatment and prophalaxis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5153192A (en) * | 1990-04-09 | 1992-10-06 | Alcon Laboratories, Inc. | Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
US5378703A (en) * | 1990-04-09 | 1995-01-03 | Alcon Laboratories, Inc. | Sulfonamides useful as carbonic anhydrase inhibitors |
TR199801665T2 (xx) * | 1996-02-26 | 1998-12-21 | Advanced Research & Technology Institute | Makular �demin engellenmesi i�in karbonik anhidraz inhibit�rlerinin kullan�m�. |
CA2294343A1 (en) * | 1997-06-26 | 1999-01-07 | Merck & Co., Inc. | Method for optimizing retinal and optic nerve health |
-
1998
- 1998-03-09 US US09/036,960 patent/US5948801A/en not_active Expired - Lifetime
-
1999
- 1999-02-01 WO PCT/US1999/002159 patent/WO1999045929A1/en active Application Filing
- 1999-02-01 AU AU25730/99A patent/AU2573099A/en not_active Abandoned
- 1999-02-16 ZA ZA9901224A patent/ZA991224B/xx unknown
- 1999-03-08 AR ARP990100980A patent/AR015537A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US5948801A (en) | 1999-09-07 |
AU2573099A (en) | 1999-09-27 |
ZA991224B (en) | 1999-10-08 |
WO1999045929A1 (en) | 1999-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2164040T1 (es) | Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos. | |
NO20101190L (no) | Anvendelse av buprenorfin i fremstillingen av et medikament | |
ES2163504T3 (es) | Formas de dosificacion de liberacion controlada de azitromicina. | |
NZ517038A (en) | Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction | |
PT913156E (pt) | Utilizacao de proteina c activada para tratar estados hipercoagulaveis associados com sepsia | |
MX9304432A (es) | Compuestos y formulaciones farmaceuticas para el tratamiento o prevencion de la osteoporosis y la perdida de los huesos. | |
AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
ES2144119T3 (es) | Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada. | |
ES2165990T3 (es) | Thip para el tratamiento de trastornos del sueño. | |
AR028959A1 (es) | Uso de rapamicina para la manufactura de un medicamento para tratar enfermedades cardiovasculares | |
PL310476A1 (en) | Application of lamotrigin in treating neuro-aids diseases | |
NO20032027D0 (no) | Effektive antitumorbehandlinger | |
AR023687A1 (es) | Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa | |
BR0107628A (pt) | l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial | |
AR037524A1 (es) | Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion | |
IL156798A0 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependency | |
PT1150704E (pt) | Melagatran para o tratamento da inflamacao | |
ES2172171T3 (es) | Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles. | |
AR015537A1 (es) | Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina. | |
UY26171A1 (es) | Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía | |
AR034142A1 (es) | Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion | |
AR004330A1 (es) | Uso de inhibidores de colinesterasa en el tratamiento de xerostomia | |
AR109456A2 (es) | Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación | |
AR008155A1 (es) | Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres. | |
BR0314364A (pt) | Uso de inibidores de pde iv para tratar angiogênese |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |